Llwytho...

An Update on SGLT2 Inhibitors for the Treatment of Diabetes Mellitus

PURPOSE OF REVIEW: SGLT2 inhibitors are the newest class of oral anti-hyperglycemic agents that have been approved for the treatment of diabetes mellitus. Over the past year there have been significant developments in both the safety and efficacy of this class of medications that are presented in th...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Curr Opin Endocrinol Diabetes Obes
Prif Awduron: Hsia, Daniel S, Grove, Owen, Cefalu, William T
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2017
Pynciau:
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6028052/
https://ncbi.nlm.nih.gov/pubmed/27898586
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MED.0000000000000311
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!